Profile: Hutchinson Technology Inc (HTCH.F)
19 Dec 2013
Hutchinson Technology Incorporated (HTI), incorporated in 1965, is a global technology manufacturer. The Company is a supplier of suspension assemblies for hard disk drives. The Company operates in two segments: the Disk Drive Components Division and the BioMeasurement Division. Its Disk Drive Components Division is a global supplier of suspension assemblies for hard disk drives. Suspension assemblies are electro-mechanical components that hold a disk drive’s read/write head at microscopic distances above the drive’s disks. Its BioMeasurement Division is focused on bringing technologies and products to the market that provide information clinicians. InSpectra StO2 devices provide clinicians the ability to detect changes in a patient’s perfusion status, and help in the early detection of hypoperfusion to enable assessment of oxygen delivery to vital organs and tissue in critical care settings.
Disk Drive Components
The Company's Disk Drive Components Division manufactures suspension assemblies for all sizes and types of hard disk drives. Suspension assemblies are components of disk drives that hold the read/write heads in position above the spinning magnetic disks. It manufactures suspension assemblies with technology and processes with very low part-to-part variation. During fiscal year ended September 25, 2011 (fiscal 2011), it shipped 454 million suspension assemblies of all types, supplying all manufacturers of disk drives and head-gimbal assemblers. During fiscal 2011, it shipped 238 million TSA+ suspension assemblies.
The Company competes with Nihon Hatsujo Kabusikigaisha, Magnecomp Precision Technology Public Company Limited, NAT Peripheral (H.K.) Co., Ltd., Nitto Denko Corporation and Dai Nippon Corporation.
The Company's InSpectra StO2 System are used in trauma, critical care and emergency medicine settings, where there is a need to monitor the compromised tissue perfusion associated with hemorrhagic and other forms of shock. The device provides measure of StO2, which quantifies the ratio of oxygenated hemoglobin to total hemoglobin in the microcirculation of skeletal or peripheral muscle. This measurement helps clinicians assess and detect changes in the patient’s overall perfusion status. The InSpectra StO2 System uses near infrared spectroscopy to noninvasively provide a continuous, real-time and direct measurement of StO2 in the thenar muscle tissue. The InSpectra StO2 Tissue Oxygenation Monitor is configured for use with the single-use sensor, which is applied to the thenar eminence. It provides consistent results among patients, with influence from factors, such as adipose tissue, edema and differences in tissue densities. The InSpectra StO2 System provides a direct, real-time and continuous regional tissue oxygen reading. Pulse oximeters give clinicians an indication of arterial oxygenation, but the measurement they provide of SpO2 represents oxygen saturation of blood before it enters the tissue region where oxygen is significantly consumed. In fiscal 2011, the Company launched a new product, the InSpectra StO2 Spot Check to quickly assess tissue perfusion and identify patients who would benefit from the use of StO2 monitoring, as well as have monitoring incorporated into the continuum of patient care from entry into the hospital through the patient’s treatment course and discharge.
The Company competes with Nonin Medical , Covidien plc, CAS Medical Systems, Inc. and ViOptix, Inc.
Hutchinson Technology Inc
40 West Highland Park Drive NE
HUTCHINSON MN 55350-9784